Green Cross, Stock Price +1.79% at This Time... 113,808 Shares Net Bought by Individuals in the Last 5 Days

As of 1:30 PM on the 14th, Green Cross is trading at 199,000 KRW, up 1.79% from the previous day. The trading volume is 776,341 shares, which is about 50.71% of the previous day's volume. Green Cross is known as a pharmaceutical company specializing in blood products and vaccines.

On July 10th, Minjeong Seon, a researcher at Hana Financial Investment, stated, "The second-quarter earnings were weak due to being pre-reflected in the first quarter and deferred to the third quarter. Due to the expansion of flu vaccine vaccinations caused by the COVID-19 virus, record-high third-quarter earnings are expected, and Green Cross, which is also developing a COVID-19 plasma treatment, can be considered a true beneficiary stock of COVID-19." She set the target price for Green Cross at 240,000 KRW.

Over the past five days, individual investors have net purchased 113,808 shares of Green Cross, while foreign investors and institutions have net sold 24,330 shares and 97,022 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.